KP Tissue Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings From Equity Investments	8.07	1.87	-1.86	-13.3	0.8
EBT Excluding Unusual Items	8.07	1.87	-1.86	-13.3	0.8
Gain (Loss) on Sale of Investments	0.43	0.62	1.03	0.75	0.32
Pretax Income	8.5	2.49	-0.83	-12.55	1.12
Income Tax Expense	-	0.06	4.11	-2.3	-0.12
Net Income	8.5	2.43	-4.94	-10.25	1.24
Net Income to Common	8.5	2.43	-4.94	-10.25	1.24
Net Income Growth	249.53%	-	-	-	-
Shares Outstanding (Basic)	10	10	10	10	10
Shares Outstanding (Diluted)	10	10	10	10	10
Shares Change (YoY)	0.27%	0.21%	0.20%	1.02%	1.36%
EPS (Basic)	0.85	0.24	-0.50	-1.03	0.13
EPS (Diluted)	0.85	0.24	-0.50	-1.03	0.13
EPS Growth	248.59%	-	-	-	-
Dividend Per Share	0.720	0.720	0.720	0.720	0.720
Effective Tax Rate	-	2.25%	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.